Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 4, 2018
Subject: Regulation FD Disclosure regarding presentation slides for the fiscal second quarter ended November 30, 2017.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to furnish presentation slides (Exhibit 99.1) containing such information, which are not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Material Changes
No material changes to financial results or operations are detailed within the text of this Form 8-K. The document references the existence of presentation materials discussing the fiscal second quarter but does not summarize the content of those materials.
Guidance, Outlook, and Risks
Management Commentary: The filing indicates that presentation slides discussing the company and its fiscal second quarter results are being furnished.
Legal Status of Information: The information contained in the attached slides is explicitly stated not to be "filed" and shall not be incorporated by reference into other filings under the Securities Act of 1933.
Risks and Contingencies: No specific risks or contingencies are disclosed in the body of this report.
Investor Verification Checklist
- Review Exhibit 99.1 (Presentation dated January 4, 2018) for actual financial figures and management commentary.
- Verify that the presentation slides are not considered "filed" documents for liability purposes under Section 18 of the Exchange Act.
- Confirm the fiscal second quarter end date of November 30, 2017, aligns with the company's reporting calendar.